Cargando…

Early-Life Antibiotic Exposure Associated With Varicella Occurrence and Breakthrough Infections: Evidence From Nationwide Pre-Vaccination and Post-Vaccination Cohorts

BACKGROUND: Antibiotic-driven dysbiosis may impair immune function and reduce vaccine-induced antibody titers. OBJECTIVES: This study aims to investigate the impacts of early-life antibiotic exposure on subsequent varicella and breakthrough infections. METHODS: This is a nationwide matched cohort st...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Teng-Li, Fan, Yi-Hsuan, Chang, Yi-Ling, Ho, Hsiu J., Liang, Li-Lin, Chen, Yi-Ju, Wu, Chun-Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011717/ https://www.ncbi.nlm.nih.gov/pubmed/35432330 http://dx.doi.org/10.3389/fimmu.2022.848835

Ejemplares similares

Epidemiology of Breakthrough Varicella after the Implementation of a Universal Varicella Vaccination Program in Taiwan, 2004–2014
por: Cheng, Hao-Yuan, et al.
Publicado: (2018)

Age-Dependent Pre-Vaccination Immunity Affects the Immunogenicity of Varicella Zoster Vaccination in Middle-aged Adults
por: van der Heiden, Marieke, et al.
Publicado: (2018)

Failure of a Single Varicella Vaccination to Protect Children With Cancer From Life-Threatening Breakthrough Varicella
por: Kelley, James, et al.
Publicado: (2015)

Varicella outbreak in the patients during group therapy: seroprevalence in a healthcare system during breakthrough varicella occurrence
por: Park, Cheong Soo, et al.
Publicado: (2013)

The occurrence of varicella after zoster vaccination in a patient with rheumatoid arthritis receiving tofacitinib
por: KAO, Chung-Mao, et al.
Publicado: (2021)

Personalized Dendritic Cell Vaccines—Recent Breakthroughs and Encouraging Clinical Results
por: Mastelic-Gavillet, Beatris, et al.
Publicado: (2019)

Immune Profile and Clinical Outcome of Breakthrough Cases After Vaccination With an Inactivated SARS-CoV-2 Vaccine
por: Duarte, Luisa F., et al.
Publicado: (2021)

Varicella-zoster virus seroprevalence in children and adolescents in the pre-varicella vaccine era, Germany
por: Wiese-Posselt, Miriam, et al.
Publicado: (2017)

Varicella Vaccine
por: Duff, Patrick
Publicado: (1996)

Computation of Antigenicity Predicts SARS-CoV-2 Vaccine Breakthrough Variants
por: Hu, Ye-Fan, et al.
Publicado: (2022)

Developing dendritic cell for SARS-CoV-2 vaccine: Breakthrough in the pandemic
por: Jonny, Jonny, et al.
Publicado: (2022)

Influenza breakthrough infection in vaccinated mice is characterized by non-pathological lung eosinophilia
por: Chang, Lauren A., et al.
Publicado: (2023)

Impact of universal varicella vaccination on the use and cost of antibiotics and antivirals for varicella management in the United States
por: Pawaskar, Manjiri, et al.
Publicado: (2022)

Effectiveness of varicella vaccination during an outbreak in a large one-dose-vaccinated population in Shanghai
por: Lin, Mingzhu, et al.
Publicado: (2022)

Immune Response in Moderate to Critical Breakthrough COVID-19 Infection After mRNA Vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Breakthrough infection evokes the nasopharyngeal innate immune responses established by SARS-CoV-2–inactivated vaccine
por: He, Xiaomeng, et al.
Publicado: (2023)

Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster
por: Gershon, Anne A, et al.
Publicado: (2021)

Implication of SARS-CoV-2 Immune Escape Spike Variants on Secondary and Vaccine Breakthrough Infections
por: Ahmad, Liyana
Publicado: (2021)

Dendritic cell activation and cytokine response in vaccine breakthrough TBE patients after in vitro stimulation with TBEV
por: Marušić, Miša, et al.
Publicado: (2023)

Analysis on the epidemiological characteristics of varicella and breakthrough case from 2014 to 2022 in Qingyang City
por: Liu, Beiqin, et al.
Publicado: (2023)

Modeling Cost-Effectiveness of Universal Varicella Vaccination With Different Varicella Vaccines in the United Kingdom
por: Pawaskar, Manjiri, et al.
Publicado: (2021)

Pre-Existing Cross-Reactive Antibody Responses Do Not Significantly Impact Inactivated COVID-19 Vaccine-Induced Neutralization
por: Wang, Jin, et al.
Publicado: (2021)

Impact of Early-Life Exposures to Infections, Antibiotics, and Vaccines on Perinatal and Long-term Health and Disease
por: Raymond, Steven L., et al.
Publicado: (2017)

Breakthrough infections due to SARS-CoV-2 Delta variant: relation to humoral and cellular vaccine responses
por: Buscot, Matthieu, et al.
Publicado: (2023)

Cost-Effectiveness of Varicella Vaccination
por: Yasri, Sora, et al.
Publicado: (2019)

Global varicella vaccination programs
por: Lee, Young Hwa, et al.
Publicado: (2022)

Varicella Vaccination Alters the Chronological Trends of Herpes Zoster and Varicella
por: Wu, Po-Yuan, et al.
Publicado: (2013)

Economic burden of varicella in Europe in the absence of universal varicella vaccination
por: Pawaskar, Manjiri, et al.
Publicado: (2021)

No Consistent Evidence of Decreased Exposure to Varicella-Zoster Virus Among Older Adults in Countries with Universal Varicella Vaccination
por: Carryn, Stephane, et al.
Publicado: (2021)

Twelve Children with Varicella Vaccine Meningitis: Neuropathogenesis of Reactivated Live Attenuated Varicella Vaccine Virus
por: Heusel, Ethan H., et al.
Publicado: (2020)

Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
por: Ruhl, Louisa, et al.
Publicado: (2023)

Life-Threatening Influenza, Hemophagocytic Lymphohistiocytosis and Probable Vaccine-Strain Varicella in a Novel Case of Homozygous STAT2 Deficiency
por: Freij, Bishara J., et al.
Publicado: (2021)

Kinetics of SARS-CoV-2 neutralizing antibodies in Omicron breakthrough cases with inactivated vaccination: Role in inferring the history and duration of infection
por: Simayi, Aidibai, et al.
Publicado: (2023)

Effect of Earlier Vaccination and a Two-Dose Varicella Vaccine Schedule on Varicella Incidence — Beijing Municipality, 2007–2018
por: Zhao, Dan, et al.
Publicado: (2021)

A Single Vaccination of Chimeric Bivalent Virus-Like Particle Vaccine Confers Protection Against H9N2 and H3N2 Avian Influenza in Commercial Broilers and Allows a Strategy of Differentiating Infected from Vaccinated Animals
por: Sun, Yi-xue, et al.
Publicado: (2022)

COVID-19 Breakthrough Infections in Vaccinated Kidney Transplant Recipients
por: Zhang, Xiaojing, et al.
Publicado: (2022)

Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
por: Almendro-Vázquez, Patricia, et al.
Publicado: (2022)

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity
por: Søraas, Arne, et al.
Publicado: (2022)

Humoral and cellular immunogenicity of homologous and heterologous booster vaccination in Ad26.COV2.S-primed individuals: Comparison by breakthrough infection
por: Hyun, Hakjun, et al.
Publicado: (2023)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_l9190i24bk63l6obtfo8dh7e84